Cargando…

Membrane proteomic analysis of pancreatic cancer cells

BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify po...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaojun, Zhang, Min, Go, Vay Liang W, Hu, Shen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949717/
https://www.ncbi.nlm.nih.gov/pubmed/20831833
http://dx.doi.org/10.1186/1423-0127-17-74
_version_ 1782187562570350592
author Liu, Xiaojun
Zhang, Min
Go, Vay Liang W
Hu, Shen
author_facet Liu, Xiaojun
Zhang, Min
Go, Vay Liang W
Hu, Shen
author_sort Liu, Xiaojun
collection PubMed
description BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify potential target proteins related to metastasis of pancreatic cancer. METHODS: Membrane/membrane-associated proteins were isolated from AsPC-1 and BxPC-3 cells and identified with a proteomic approach based on SDS-PAGE, in-gel tryptic digestion and liquid chromatography with tandem mass spectrometry (LC-MS/MS). X! Tandem was used for database searching against the SwissProt human protein database. RESULTS: We identified 221 & 208 proteins from AsPC-1 and BxPC-3 cells, respectively, most of which are membrane or membrane-associated proteins. A hundred and nine proteins were found in both cell lines while the others were present in either AsPC-1 or BxPC-3 cells. Differentially expressed proteins between two cell lines include modulators of cell adhesion, cell motility or tumor invasion as well as metabolic enzymes involved in glycolysis, tricarboxylic acid cycle, or nucleotide/lipid metabolism. CONCLUSION: Membrane proteomes of AsPC-1 (metastatic) and BxPC-3 (primary) cells are remarkably different. The differentially expressed membrane proteins may serve as potential targets for diagnostic and therapeutic interventions.
format Text
id pubmed-2949717
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29497172010-10-06 Membrane proteomic analysis of pancreatic cancer cells Liu, Xiaojun Zhang, Min Go, Vay Liang W Hu, Shen J Biomed Sci Research BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify potential target proteins related to metastasis of pancreatic cancer. METHODS: Membrane/membrane-associated proteins were isolated from AsPC-1 and BxPC-3 cells and identified with a proteomic approach based on SDS-PAGE, in-gel tryptic digestion and liquid chromatography with tandem mass spectrometry (LC-MS/MS). X! Tandem was used for database searching against the SwissProt human protein database. RESULTS: We identified 221 & 208 proteins from AsPC-1 and BxPC-3 cells, respectively, most of which are membrane or membrane-associated proteins. A hundred and nine proteins were found in both cell lines while the others were present in either AsPC-1 or BxPC-3 cells. Differentially expressed proteins between two cell lines include modulators of cell adhesion, cell motility or tumor invasion as well as metabolic enzymes involved in glycolysis, tricarboxylic acid cycle, or nucleotide/lipid metabolism. CONCLUSION: Membrane proteomes of AsPC-1 (metastatic) and BxPC-3 (primary) cells are remarkably different. The differentially expressed membrane proteins may serve as potential targets for diagnostic and therapeutic interventions. BioMed Central 2010-09-13 /pmc/articles/PMC2949717/ /pubmed/20831833 http://dx.doi.org/10.1186/1423-0127-17-74 Text en Copyright ©2010 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Liu, Xiaojun
Zhang, Min
Go, Vay Liang W
Hu, Shen
Membrane proteomic analysis of pancreatic cancer cells
title Membrane proteomic analysis of pancreatic cancer cells
title_full Membrane proteomic analysis of pancreatic cancer cells
title_fullStr Membrane proteomic analysis of pancreatic cancer cells
title_full_unstemmed Membrane proteomic analysis of pancreatic cancer cells
title_short Membrane proteomic analysis of pancreatic cancer cells
title_sort membrane proteomic analysis of pancreatic cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949717/
https://www.ncbi.nlm.nih.gov/pubmed/20831833
http://dx.doi.org/10.1186/1423-0127-17-74
work_keys_str_mv AT liuxiaojun membraneproteomicanalysisofpancreaticcancercells
AT zhangmin membraneproteomicanalysisofpancreaticcancercells
AT govayliangw membraneproteomicanalysisofpancreaticcancercells
AT hushen membraneproteomicanalysisofpancreaticcancercells